240 related articles for article (PubMed ID: 26806867)
21. Activation of PI3K is associated with reduced survival in renal cell carcinoma.
Merseburger AS; Hennenlotter J; Kuehs U; Simon P; Kruck S; Koch E; Stenzl A; Kuczyk MA
Urol Int; 2008; 80(4):372-7. PubMed ID: 18587247
[TBL] [Abstract][Full Text] [Related]
22. Hyperoside protects primary rat cortical neurons from neurotoxicity induced by amyloid β-protein via the PI3K/Akt/Bad/Bcl(XL)-regulated mitochondrial apoptotic pathway.
Zeng KW; Wang XM; Ko H; Kwon HC; Cha JW; Yang HO
Eur J Pharmacol; 2011 Dec; 672(1-3):45-55. PubMed ID: 21978835
[TBL] [Abstract][Full Text] [Related]
23. Expression analysis of dopaminergic neurons in Parkinson's disease and aging links transcriptional dysregulation of energy metabolism to cell death.
Elstner M; Morris CM; Heim K; Bender A; Mehta D; Jaros E; Klopstock T; Meitinger T; Turnbull DM; Prokisch H
Acta Neuropathol; 2011 Jul; 122(1):75-86. PubMed ID: 21541762
[TBL] [Abstract][Full Text] [Related]
24. Inactivation of the Akt survival pathway during photoreceptor apoptosis in the retinal degeneration mouse.
Jomary C; Cullen J; Jones SE
Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1620-9. PubMed ID: 16565401
[TBL] [Abstract][Full Text] [Related]
25. Interleukin-18 directly protects cortical neurons by activating PI3K/AKT/NF-κB/CREB pathways.
Zhou J; Ping FF; Lv WT; Feng JY; Shang J
Cytokine; 2014 Sep; 69(1):29-38. PubMed ID: 25022959
[TBL] [Abstract][Full Text] [Related]
26. DJ-1-binding compound B enhances Nrf2 activity through the PI3-kinase-Akt pathway by DJ-1-dependent inactivation of PTEN.
Niki T; Endo J; Takahashi-Niki K; Yasuda T; Okamoto A; Saito Y; Ariga H; Iguchi-Ariga SMM
Brain Res; 2020 Feb; 1729():146641. PubMed ID: 31891690
[TBL] [Abstract][Full Text] [Related]
27. FLZ protects dopaminergic neuron through activating protein kinase B/mammalian target of rapamycin pathway and inhibiting RTP801 expression in Parkinson's disease models.
Bao XQ; Kong XC; Qian C; Zhang D
Neuroscience; 2012 Jan; 202():396-404. PubMed ID: 22138155
[TBL] [Abstract][Full Text] [Related]
28. Caffeine activates the PI3K/Akt pathway and prevents apoptotic cell death in a Parkinson's disease model of SH-SY5Y cells.
Nakaso K; Ito S; Nakashima K
Neurosci Lett; 2008 Feb; 432(2):146-50. PubMed ID: 18201823
[TBL] [Abstract][Full Text] [Related]
29. The silence of p66(Shc) in HCT8 cells inhibits the viability via PI3K/AKT/Mdm-2/p53 signaling pathway.
Zhang L; Zhu S; Shi X; Sha W
Int J Clin Exp Pathol; 2015; 8(8):9097-104. PubMed ID: 26464652
[TBL] [Abstract][Full Text] [Related]
30. Enhancement of DC vaccine potency by activating the PI3K/AKT pathway with a small interfering RNA targeting PTEN.
Kim JH; Kang TH; Noh KH; Kim SH; Lee YH; Kim KW; Bae HC; Ahn YH; Choi EY; Kim JS; Lee KM; Kim TW
Immunol Lett; 2010 Nov; 134(1):47-54. PubMed ID: 20727912
[TBL] [Abstract][Full Text] [Related]
31. Neuroprotective effects of geniposide in the MPTP mouse model of Parkinson's disease.
Chen Y; Zhang Y; Li L; Hölscher C
Eur J Pharmacol; 2015 Dec; 768():21-7. PubMed ID: 26409043
[TBL] [Abstract][Full Text] [Related]
32. Sitagliptin and liraglutide reversed nigrostriatal degeneration of rodent brain in rotenone-induced Parkinson's disease.
Badawi GA; Abd El Fattah MA; Zaki HF; El Sayed MI
Inflammopharmacology; 2017 Jun; 25(3):369-382. PubMed ID: 28258522
[TBL] [Abstract][Full Text] [Related]
33. Nuclear phosphatidylinositol 3,4,5-trisphosphate, phosphatidylinositol 3-kinase, Akt, and PTen: emerging key regulators of anti-apoptotic signaling and carcinogenesis.
Martelli AM; Cocco L; Capitani S; Miscia S; Papa S; Manzoli FA
Eur J Histochem; 2007; 51 Suppl 1():125-31. PubMed ID: 17703603
[TBL] [Abstract][Full Text] [Related]
34. TOPK/PBK promotes cell migration via modulation of the PI3K/PTEN/AKT pathway and is associated with poor prognosis in lung cancer.
Shih MC; Chen JY; Wu YC; Jan YH; Yang BM; Lu PJ; Cheng HC; Huang MS; Yang CJ; Hsiao M; Lai JM
Oncogene; 2012 May; 31(19):2389-400. PubMed ID: 21996732
[TBL] [Abstract][Full Text] [Related]
35. Leaf extract of Rhus verniciflua Stokes protects dopaminergic neuronal cells in a rotenone model of Parkinson's disease.
Kim S; Park SE; Sapkota K; Kim MK; Kim SJ
J Pharm Pharmacol; 2011 Oct; 63(10):1358-67. PubMed ID: 21899552
[TBL] [Abstract][Full Text] [Related]
36. PI3K/AKT signaling activation by roflumilast ameliorates rotenone-induced Parkinson's disease in rats.
Farid HA; Sayed RH; El-Shamarka ME; Abdel-Salam OME; El Sayed NS
Inflammopharmacology; 2024 Apr; 32(2):1421-1437. PubMed ID: 37541971
[TBL] [Abstract][Full Text] [Related]
37. Induction of B-chronic lymphocytic leukemia cell apoptosis by arsenic trioxide involves suppression of the phosphoinositide 3-kinase/Akt survival pathway via c-jun-NH2 terminal kinase activation and PTEN upregulation.
Redondo-Muñoz J; Escobar-Díaz E; Hernández Del Cerro M; Pandiella A; Terol MJ; García-Marco JA; García-Pardo A
Clin Cancer Res; 2010 Sep; 16(17):4382-91. PubMed ID: 20534739
[TBL] [Abstract][Full Text] [Related]
38. Differential sensitivity of human glioblastoma LN18 (PTEN-positive) and A172 (PTEN-negative) cells to Taxol for apoptosis.
Zhang R; Banik NL; Ray SK
Brain Res; 2008 Nov; 1239():216-25. PubMed ID: 18804099
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma.
Go H; Jang JY; Kim PJ; Kim YG; Nam SJ; Paik JH; Kim TM; Heo DS; Kim CW; Jeon YK
Oncotarget; 2015 Jun; 6(17):15035-49. PubMed ID: 25909227
[TBL] [Abstract][Full Text] [Related]
40. Involvement of Bcl-2 family members, phosphatidylinositol 3'-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer.
Shankar S; Srivastava RK
Int J Oncol; 2007 Apr; 30(4):905-18. PubMed ID: 17332930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]